Clinical Trials in Phoenix

Showing 14041-14060 of 16,646 trials

VEC-162 Study in Healthy Adult Volunteers in a Model of Insomnia

NCT00291187

The purpose of this study is to determine the safety and efficacy of VEC-162 compared to placebo to improve sleep parameters in a model of insomnia.

Insomnia

Vanda Pharmaceuticals411 participantsStarted Feb 2006

Birmingham, Alabama, United States • Phoenix, Arizona, United States • San Diego, California, United States +16 more locations

COMPLETEDPhase 4< 1 mile

A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Etravirine Administered in Combination With Other Antiretroviral Agents in Antiretroviral Treatment-Experienced HIV-1 Infected Patients

NCT01422330

The purpose of this study is to learn more about the safety and tolerability of etravirine. Etravirine is a type of non-nucleoside reverse transcriptase inhibitor (NNRTI) which has shown high activity against wild-type human immunodeficiency virus (HIV-1), and HIV strains resistant to other non-nucleotide agents.

Human Immunodeficiency Virus (HIV) Infection

Janssen R&D Ireland211 participantsStarted Sep 2011

Phoenix, Arizona, United States • Beverly Hills, California, United States • North Hollywood, California, United States +39 more locations

VEC-162 Study in Healthy Adult Volunteers in a Model of Insomnia

A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Etravirine Administered in Combination With Other Antiretroviral Agents in Antiretroviral Treatment-Experienced HIV-1 Infected Patients

Find Trials by Condition in Phoenix

Withdrawal Study to Demonstrate the Maintenance Effect in the Treatment of Non-24-Hour Sleep-Wake Disorder

A Clinical Investigation to Evaluate Efficacy of Mepitel Ag in Partial Thickness Second Degree Burns

Safety & Efficacy Study Evaluating the Combination of Bevasiranib & Lucentis Therapy in Wet AMD

A Study of Ramucirumab in Participants With Gastric, Esophageal, and Gastroesophageal Cancer

A Transplant or Cancer Resilience Intervention

Efficacy and Safety in Subjects With Type 2 Diabetes Receiving Subcutaneous Basal Insulin and Prandial Inhalation of Technosphere/Insulin Versus Subcutaneous Premixed Insulin Therapy Over a 52-Week Treatment Period and a 4-Week Follow-up

VEC-162 Study in Adult Patients With Primary Insomnia

When to Start Anti-HIV Drugs in Patients With Opportunistic Infections

Weight Loss Study for People With Type 2 Diabetes

To Compare Treatment With Doxorubicin or Capecitabine for Metastatic Breast Cancer in Women 60 Years and Older

A Study to Evaluate the Pharmacokinetics of PCI-32765 in Participants With Varying Degrees of Hepatic Impairment

Assessing the Pharmacokinetics of NKTR-118 in Subjects With Renal Impairment Compared to That in Subjects With Normal Renal Function

AZD6765 Single and Multiple Ascending Dose Study in Healthy Male and Female Japanese and Caucasian Subjects

A Study of Trastuzumab Emtansine (T-DM1) Sequentially With Anthracycline-based Chemotherapy, as Adjuvant or Neoadjuvant Therapy for Patients With Early Stage Herceptin (HER)2-positive Breast Cancer

A Study of the Effect of LY2189265 on Two Blood Pressure Drugs

A Study of LY2189265 and Sitagliptin in Participants With Type 2 Diabetes

HMO Research Network CERT: Acute Myocardial Infarction

Evaluation of Metabolic Acid-base Abnormalities in Pre-eclamptic Women Applying the Stewart-Fencl Approach